Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 3
1991 1
1992 4
1993 4
1995 2
1996 3
2003 1
2005 1
2006 2
2008 1
2010 3
2011 5
2012 3
2015 1
2017 3
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Tolvaptan: a new therapeutic agent.
Aperis G, Alivanis P. Aperis G, et al. Among authors: alivanis p. Rev Recent Clin Trials. 2011 May;6(2):177-88. doi: 10.2174/157488711795177895. Rev Recent Clin Trials. 2011. PMID: 20868352 Review.
The role of paricalcitol on proteinuria.
Aperis G, Paliouras C, Zervos A, Arvanitis A, Alivanis P. Aperis G, et al. Among authors: alivanis p. J Ren Care. 2011 Jun;37(2):80-4. doi: 10.1111/j.1755-6686.2011.00229.x. J Ren Care. 2011. PMID: 21561543 Clinical Trial.
Posaconazole: a new antifungal weapon.
Aperis G, Alivanis P. Aperis G, et al. Among authors: alivanis p. Rev Recent Clin Trials. 2011 Sep;6(3):204-19. doi: 10.2174/157488711796575595. Rev Recent Clin Trials. 2011. PMID: 21682687 Review.
Anacetrapib: a new weapon against dyslipidemia.
Aperis G, Paliouras C, Tsampikaki E, Papakonstantinou N, Alivanis P. Aperis G, et al. Among authors: alivanis p. Curr Clin Pharmacol. 2011 Nov;6(4):227-35. doi: 10.2174/157488411798375949. Curr Clin Pharmacol. 2011. PMID: 22082322 Review.
Novel and Founder Pathogenic Variants in X-Linked Alport Syndrome Families in Greece.
Hadjipanagi D, Papagregoriou G, Koutsofti C, Polydorou C, Alivanis P, Andrikos A, Christodoulidou S, Dardamanis M, Diamantopoulos AA, Fountoglou A, Frangou E, Georgaki E, Giannikouris I, Gkinis V, Goudas PC, Kalaitzidis RG, Kaperonis N, Koutroumpas G, Makrydimas G, Myserlis G, Mitsioni A, Paliouras C, Papachristou F, Papadopoulou D, Papagalanis N, Papagianni A, Perysinaki G, Siomou E, Sombolos K, Tzanakis I, Vergoulas GV, Printza N, Deltas C. Hadjipanagi D, et al. Among authors: alivanis p. Genes (Basel). 2022 Nov 24;13(12):2203. doi: 10.3390/genes13122203. Genes (Basel). 2022. PMID: 36553470 Free PMC article.
A pilot study of piracetam in cuprophan hemodialysis.
Grekas D, Alivanis P, Karamouzis M, Pyrpasopoulos M, Tourkantonis A. Grekas D, et al. Among authors: alivanis p. Artif Organs. 1989 Oct;13(5):422-6. doi: 10.1111/j.1525-1594.1989.tb01551.x. Artif Organs. 1989. PMID: 2803050 Clinical Trial.
38 results